Orphazyme A/S ADR (ORPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2003 | 09-2003 | 06-2003 | 03-2003 | 12-2002 | |
| Gross Profit | 3,180 | 2,480 | 3,630 | 3,820 | 4,270 |
| Operating Expenses | 4,680 | 2,540 | 1,890 | 1,690 | 1,960 |
| Operating Income | -4,680 | -2,540 | -1,890 | -1,690 | -1,960 |
| Pre-tax Income | -4,680 | -2,540 | -1,890 | -1,690 | -1,960 |
| Net Income Continuous | -4,680 | -2,540 | -1,890 | -1,690 | -1,960 |
| Net Income | $-4,680 | $-2,540 | $-1,890 | $-1,690 | $-1,960 |
| EBITDA(a) | $-4,570 | $-2,390 | $-1,760 | $-1,580 | $-1,860 |